Phase 1/2 Trial of the Oral EGFR/HER2 Inhibitor AP32788 in Non-Small Cell Lung Cancer (NSCLC)Robert Doebele,Leora Horn,Alexander Spira,Zofia Piotrowska,Daniel Costa,Joel Neal,William Reichmann,David Kerstein,Shuanglian Li,Pasi JanneJOURNAL OF THORACIC ONCOLOGY(2017)引用 0|浏览5暂无评分关键词EGFR,HER2,AP32788,NSCLCAI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要